{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,21]],"date-time":"2026-11-21T18:53:23Z","timestamp":1795287203649,"version":"4.10.3"},"reference-count":14,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"9","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2024,9]]},"abstract":"<jats:sec>\n            <jats:title>Purpose:<\/jats:title>\n            <jats:p>The aim of the study was to evaluate the efficacy and safety of quantum molecular resonance in the treatment of dry eye disease.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods:<\/jats:title>\n            <jats:p>This study was a double-blind randomized control trial in 1 academic medical center, for 2 years. Participants received treatment or a placebo with the Rexon-Eye device, once per week for 4 weeks. The primary outcome was the change in dry eye symptoms assessed by the Ocular Surface Disease Index (OSDI). Secondary outcomes were clinical findings associated with the dry eye such as meibomian gland dysfunction (MGD) score, tear break-up time (TBUT), corneal fluorescein staining, Schirmer test, and best-corrected visual acuity (BCVA).<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results:<\/jats:title>\n            <jats:p>Forty patients were recruited, 20 in each arm. The mean age was 63.5 \u00b1 15.1 years and 27 (67.5%) were female. The mean OSDI score significantly improved in the intervention group from 19.15 \u00b1 10.3 to 10.5 \u00b1 7.0 (<jats:italic toggle=\"yes\">P<\/jats:italic> &lt; 0.001), whereas the control group showed no significant change (14.4 \u00b1 8.4 to 15.5 \u00b1 8.6, <jats:italic toggle=\"yes\">P<\/jats:italic> = 0.830). MGD scores significantly improved in the intervention group (1.57 \u00b1 1.2 to 0.8 \u00b1 0.9, <jats:italic toggle=\"yes\">P<\/jats:italic> = 0.006), whereas showing no significant change in the control group (1.60 \u00b1 0.9 to 1.99 \u00b1 1.0, <jats:italic toggle=\"yes\">P<\/jats:italic> = 0.244). The corneal staining score also showed significant improvement in the intervention group (<jats:italic toggle=\"yes\">P<\/jats:italic> = 0.045) and a nonsignificant decline in the placebo group (<jats:italic toggle=\"yes\">P<\/jats:italic> = 0.50). No significant difference was seen in TBUT, visual acuity, and Schirmer scores between groups. No harm resulting from treatment was reported during the duration of the trial.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions:<\/jats:title>\n            <jats:p>High-frequency electrotherapy may have a positive effect on symptoms and signs of dry eye. This emerging technology may become part of the arsenal of therapeutic modalities for this condition.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/ico.0000000000003443","type":"journal-article","created":{"date-parts":[[2024,1,2]],"date-time":"2024-01-02T16:08:51Z","timestamp":1704211731000},"page":"1144-1149","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":9,"title":["Quantum Molecular Resonance Effects on Patients With Dry Eye Disease: A Randomized Controlled Trial"],"prefix":"10.1097","volume":"43","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4366-5438","authenticated-orcid":false,"given":"Asaf","family":"Shemer","sequence":"first","affiliation":[{"name":"Department of Ophthalmology, Shamir Medical Center (formerly Assaf-Harofeh), Tzrifin, Israel;"},{"name":"Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aya","family":"Altarescu","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, Shamir Medical Center (formerly Assaf-Harofeh), Tzrifin, Israel;"},{"name":"Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lee","family":"Nusbaum","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, Shamir Medical Center (formerly Assaf-Harofeh), Tzrifin, Israel;"},{"name":"Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maya","family":"Vardi","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, Shamir Medical Center (formerly Assaf-Harofeh), Tzrifin, Israel;"},{"name":"Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Biana","family":"Dubinsky-Pertzov","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, Shamir Medical Center (formerly Assaf-Harofeh), Tzrifin, Israel;"},{"name":"Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Idan","family":"Hecht","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, Shamir Medical Center (formerly Assaf-Harofeh), Tzrifin, Israel;"},{"name":"Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lior","family":"Or","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, Shamir Medical Center (formerly Assaf-Harofeh), Tzrifin, Israel;"},{"name":"Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adi","family":"Einan-Lifshitz","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, Shamir Medical Center (formerly Assaf-Harofeh), Tzrifin, Israel;"},{"name":"Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eran","family":"Pras","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, Shamir Medical Center (formerly Assaf-Harofeh), Tzrifin, Israel;"},{"name":"Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel; and"},{"name":"The Matlow's Ophthalmo-Genetics Laboratory, Department of Ophthalmology, Shamir Medical Center (formerly Assaf-Harofeh), Tzrifin, Israel."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2023,12,28]]},"reference":[{"key":"R1-20250723","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1016\/j.jtos.2017.05.009","article-title":"TFOS DEWS II clinical trial design report","volume":"15","author":"Novack","year":"2017","journal-title":"Ocul Surf."},{"key":"R2-20250723","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/j.ajo.2006.11.060","article-title":"Impact of dry eye syndrome on vision-related quality of life","volume":"143","author":"Miljanovi\u0107","year":"2007","journal-title":"Am J Ophthalmol."},{"key":"R3-20250723","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1097\/ICU.0000000000000569","article-title":"Advances in dry eye disease treatment","volume":"30","author":"O'Neil","year":"2019","journal-title":"Curr Opin Ophthalmol."},{"key":"R4-20250723","doi-asserted-by":"crossref","first-page":"e0190082","DOI":"10.1371\/journal.pone.0190082","article-title":"In-vitro analysis of quantum molecular resonance effects on human mesenchymal stromal cells","volume":"13","author":"Sella","year":"2018","journal-title":"PLoS One"},{"key":"R5-20250723","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1111\/iwj.12805","article-title":"Quantum molecular resonance technology in hard-to-heal extremity wounds: histological and clinical results","volume":"14","author":"Fraccalvieri","year":"2017","journal-title":"Int Wound J."},{"key":"R6-20250723","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1136\/bjophthalmol-2016-308678","article-title":"Transcutaneous periorbital electrical stimulation in the treatment of dry eye","volume":"101","author":"Pedrotti","year":"2017","journal-title":"Br J Ophthalmol."},{"key":"R7-20250723","doi-asserted-by":"crossref","first-page":"1424","DOI":"10.1097\/ICO.0000000000002063","article-title":"High frequency electrotherapy for the treatment of meibomian gland dysfunction","volume":"38","author":"Ferrari","year":"2019","journal-title":"Cornea"},{"key":"R8-20250723","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1080\/09273940701486803","article-title":"Ocular surface disease index for the diagnosis of dry eye syndrome","volume":"15","author":"\u00d6zcura","year":"2007","journal-title":"Ocul Immunol Inflamm."},{"key":"R9-20250723","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1016\/j.ajo.2011.08.032","article-title":"Choice of analytic approach for eye-specific outcomes: one eye or two?","volume":"153","author":"Karakosta","year":"2012","journal-title":"Am J Ophthalmol."},{"key":"R10-20250723","first-page":"49","article-title":"Biophysical effects of high frequency electrical field (4-64 MHz) on muscle fibers in culture","volume":"19","author":"Maschio","year":"2009","journal-title":"Basic Appl Myology."},{"issue":"suppl 1","key":"R11-20250723","doi-asserted-by":"crossref","first-page":"A176","DOI":"10.1186\/1129-2377-16-S1-A176","article-title":"P031. An observational study on chronic tension-type headache treatment with Quantum Molecular Resonance according to I.A.R.A. model\u00ae","volume":"16","author":"Gulotta","year":"2015","journal-title":"J Headache Pain."},{"key":"R12-20250723","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1177\/0194599814549729","article-title":"Quantum molecular resonance-assisted phonomicrosurgery: preliminary experience","volume":"152","author":"Demirhan","year":"2015","journal-title":"Otolaryngol Head Neck Surg."},{"key":"R13-20250723","doi-asserted-by":"crossref","first-page":"3530","DOI":"10.1111\/jocd.14628","article-title":"Use of quantum molecular resonance energy for managing postrhinoseptoplasty perilesional edema and ecchymosis","volume":"21","author":"Ahn","year":"2022","journal-title":"J Cosmet Dermatol."},{"key":"R14-20250723","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.optom.2022.06.003","article-title":"Evaluating the efficacy of Quantum Molecular Resonance (QMR) electrotherapy in mixed-type dry eye patients","volume":"16","author":"Trivli","year":"2023","journal-title":"J Optom."}],"container-title":["Cornea"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/ICO.0000000000003443","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,23]],"date-time":"2025-07-23T14:04:02Z","timestamp":1753279442000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/ICO.0000000000003443"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,12,28]]},"references-count":14,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2024]]}},"URL":"https:\/\/doi.org\/10.1097\/ico.0000000000003443","relation":{},"ISSN":["0277-3740"],"issn-type":[{"value":"0277-3740","type":"print"}],"subject":[],"published":{"date-parts":[[2023,12,28]]},"assertion":[{"value":"2023-08-06","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-10-29","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}